EMMALINE NEWMAN: Open Payments
NPI 1740839315 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 19 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $144 |
| Astellas Pharma US Inc | 3 | $74 |
| Lilly USA, LLC | 4 | $61 |
| ABBVIE INC. | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Biogen, Inc. | 1 | $20 |
Products named: AIRSUPRA, Veozah, MOUNJARO, Auvelity, VRAYLAR, CAPLYTA, REXULTI, SKYCLARYS.
Industry payments across TN — which companies pay providers there.
